A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2009
10/08/2009	WO2009100330A3 Platinum aggregates and process for producing the same
10/08/2009	WO2009090027A8 Carrier pellets, method for the production thereof and use thereof
10/08/2009	WO2009064681A3 Liquid compositions comprising valsartan
10/08/2009	WO2009026178A3 High concentration local anesthetic formulations
10/08/2009	WO2008121342A3 Emulsions and techniques for formation
10/08/2009	WO2008118552A9 Use of ranolazine for the treatment of cardiovascular diseases
10/08/2009	WO2008108286A9 Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same
10/08/2009	WO2008062437A3 Process for the preparation of sevelamer hydrochloride and formulation thereof
10/08/2009	US20090254191 Implant with composite coating
10/08/2009	US20090254067 Fluid delivery device
10/08/2009	US20090254024 Array and method for dosing a hormone regulating blood sugar in a patient
10/08/2009	US20090253807 Aqueous suspension preparations
10/08/2009	US20090253675 Pharmaceutical formulation
10/08/2009	US20090253645 Methods and materials for treating and preventing inflammation of mucosal tissue
10/08/2009	US20090252811 Capped mesoporous silicates
10/08/2009	US20090252810 Aryl/alkyl Succinic Anhydride-Hyaluronan Derivatives
10/08/2009	US20090252809 Microcapsules From Emulsion Polymerization of Tetraalkoxysilane
10/08/2009	US20090252808 Controlled release of biological entities
10/08/2009	US20090252807 Nanoparticulate and Controlled Release Compositions Comprising Prostaglandin Derivatives
10/08/2009	US20090252806 Nanoparticulate tacrolimus formulations
10/08/2009	US20090252805 Film-Coated and/or Granulated Calcium-Containing Compounds and Use Thereof in Pharmaceutical Compositions
10/08/2009	US20090252804 Medical devices with an antibacterial polyurethaneurea coating
10/08/2009	US20090252803 Glycyrrhetinic acid-mediated nanoparticles of hepatic targeted drug delivery system, process for preparing the same and use thereof
10/08/2009	US20090252802 Compositions Including Relatively Water Insoluble/Unwettable Drugs And Methods For Using Same
10/08/2009	US20090252801 Process for the Preparation of Micronised Sterile Steroids
10/08/2009	US20090252800 Anisotropic nanocomposite hydrogel
10/08/2009	US20090252799 Materials and methods for wound treatment
10/08/2009	US20090252798 Matrix-gel graft without cells
10/08/2009	US20090252797 Topical application of ivermectin for the treatment of dermatological conditions/afflictions
10/08/2009	US20090252796 Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance
10/08/2009	US20090252795 Bioceramic scaffolds for tissue engineering
10/08/2009	US20090252794 Tablet
10/08/2009	US20090252793 Pharmaceutical compositions
10/08/2009	US20090252792 method to reduce the symptoms of heartburn and gastro-oesophageal reflux disease (gerd) by specific polysaccharides
10/08/2009	US20090252791 Pharmaceutical compositions comprising a triptan and a nonsteroidal anti-inflammatory drug
10/08/2009	US20090252790 Tablet formulation
10/08/2009	US20090252789 One step spray-drying process
10/08/2009	US20090252788 Balsalazide formulations and manufacture and use thereof
10/08/2009	US20090252787 Granular pharmaceutical compositions
10/08/2009	US20090252786 Use of a Biologically Active Blood Serum for the Treatment of a Disorder Characterized in a Reduced Function of a GABA Receptor
10/08/2009	US20090252785 Endoplasmic reticulum targeting liposomes
10/08/2009	US20090252784 Compositions comprising inhibitors of RNA binding proteins and methods of producing and using same
10/08/2009	US20090252783 Means for inhibiting the expression of cd31
10/08/2009	US20090252782 Transdermal Preparations Containing Hydrophoic Non-Steroidal Anti-Inflammatory Drugs
10/08/2009	US20090252781 Hydrogel polymeric compositions and methods
10/08/2009	US20090252780 Coatings for implantable medical devices
10/08/2009	US20090252778 Methods and devices for reducing tissue damage after ischemic injury
10/08/2009	US20090252777 Method for formulating a controlled-release pharmaceutical formulation
10/08/2009	US20090252773 Emulsion composition
10/08/2009	US20090252770 Non-digestible sugar-coated products and process
10/08/2009	US20090252769 Preventive and therapeutic vaccine for storke and neurological disorders
10/08/2009	US20090252768 Use of stilbene derivatives for treatment and prevention of aquatic mold infections
10/08/2009	US20090252767 Water dispersible enteric coating formulation of nutraceutical and pharmaceutical dosage forms
10/08/2009	US20090252690 Flavoured Mouth Wash Composition
10/08/2009	CA2728890A1 Amide derivative-containing pharmaceutical composition
10/08/2009	CA2720577A1 Cross-linked polymer matrices, in particular for administering active ingredients
10/08/2009	CA2720480A1 Pharmaceutical preparation comprising permethylated cyclodextrin
10/08/2009	CA2720474A1 Nanocarrier and nanogel compositions
10/08/2009	CA2720418A1 Pharmaceutical composition with bisphosphonate
10/08/2009	CA2720400A1 Self-destructing transdermal therapeutic system having improved functionality and efficacy
10/08/2009	CA2720390A1 Lipid-oil-water nanoemulsion delivery system for microtubule-interacting agents
10/08/2009	CA2720183A1 Liquid and freeze dried formulations
10/08/2009	CA2720030A1 Device for in situ production and topical administration of allicin
10/08/2009	CA2718753A1 Novel oral controlled release pharmaceutical formulations
10/08/2009	CA2716010A1 Hemostatic microspheres
10/08/2009	CA2715584A1 Oral controlled release tablet
10/07/2009	EP2106815A2 External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
10/07/2009	EP2106808A1 Radioactive diagnostic imaging agent
10/07/2009	EP2106805A1 Antifungal nail coat and method of use
10/07/2009	EP2106797A2 Controlled release oxycodone compositions
10/07/2009	EP2106796A2 Controlled release oxycodone compositions
10/07/2009	EP2106793A1 Ready to use Oxaliplatin solutions
10/07/2009	EP2106790A1 Rapid acting drug delivery compositions
10/07/2009	EP2106789A1 Pharmaceutical composition comprising candesartan
10/07/2009	EP2106788A1 Liquid and freeze dried formulations
10/07/2009	EP2106787A2 Biodegradable block copolymeric compositions for drug delivery
10/07/2009	EP2106786A1 Pharmaceutical preparation comprising permethylated cyclodextrin
10/07/2009	EP2106785A1 Device and method for treating urinary incontinence in females
10/07/2009	EP2106470A2 Control and/or monitoring method for the salting-out of at leat one active ingredient impregnated in a textile<0}
10/07/2009	EP2106296A1 Method of micronization
10/07/2009	EP2106247A1 Prevention and treatment of androgen-deprivation induced skeletal-related event (sre)
10/07/2009	EP2106217A1 Active ingredient delivery system with an amorphous metal salt as carrier
10/07/2009	EP1973527B1 Processes for making particle-based pharmaceutical formulations for parenteral administration
10/07/2009	EP1898904B1 Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation
10/07/2009	EP1898889B1 Gellan seamless breakable capsule and process for manufacturing thereof
10/07/2009	EP1896006B1 A manufacturing method for entacapone-containing granules for oral dosage forms
10/07/2009	EP1706096B1 Consumer customized dosage forms
10/07/2009	EP1654002B1 Compositions for delivery of therapeutics into the eyes and methods for making and using the same
10/07/2009	EP1648413B1 Pharmaceutical compositions of short-acting sedative hypnotic agent
10/07/2009	EP1587496B1 Taste-masking coated particles, process for the preparation thereof and orodispersible tablets containing said coated particles
10/07/2009	EP1551374B1 Polymer composition and dosage forms comprising the same
10/07/2009	EP1509227B1 A buffered, liquid nicotine composition for pulmonary administration
10/07/2009	EP1501493B1 Use of epa and dha in secondary prevention of strokes
10/07/2009	EP1453488B1 Improved edible film formulations containing maltodextrin
10/07/2009	EP1392389B1 Microprojection array having a beneficial agent containing coating
10/07/2009	EP1385550B1 Therapeutic medicaments for inducing tolerance
10/07/2009	EP1372573B1 Thermally reversible water in oil in water emulsions
10/07/2009	EP1341545B1 Process for preparing a bone putty
10/07/2009	EP1311249B1 Set of transdermal therapeutic systems
10/07/2009	EP1292347B1 Drug delivery apparatus

1 ... 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 ... 2991